Mark A. Kronenfeld

Insider Reports History

Location
Tampa, FL
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Kronenfeld:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pacira BioSciences, Inc. Director Common Stock 34,901 $876,713 $25.12 11 Jun 2025 Direct
Pacira BioSciences, Inc. Director Stock Option (Right to Buy) 11,279 $323,840 $26.59 11 Jun 2025 Direct

Insider Reports Filed by Mark A. Kronenfeld

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCRX Pacira BioSciences, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:18
PCRX Pacira BioSciences, Inc. 12 Jun 2024 2 $0 4 Director 13 Jun 2024, 18:12
PCRX Pacira BioSciences, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 17:34
PCRX Pacira BioSciences, Inc. 08 Jun 2023 3 -$107,100 4 Director 12 Jun 2023, 16:16
PCRX Pacira BioSciences, Inc. 08 Jun 2022 2 $0 4 Director 08 Jun 2022, 19:29
PCRX Pacira BioSciences, Inc. 09 Jun 2021 2 $0 4 Director 11 Jun 2021, 20:33